The Role of CEBPD in Oxidative Stress and Angiogenesis Regulation in Endometriosis
article
OA: gold
CC0
Abstract
Background: Endometriosis (EM) is a prevalent gynecological disorder in women. Although the underlying mechanisms have yet to be fully elucidated, EM may be related to oxidative stress. The current research aimed to identify possible pathways that control oxidative stress in EM, thereby providing a theoretical foundation for its clinical diagnosis and treatment. Methods: High-throughput RNA sequencing (RNA-seq) data were integrated with GeneCards online data to screen for oxidative stress-related genes and potential targets in EM. The reverse transcription-quantitative polymerase chain reaction (RT-qPCR), Western blotting, and immunohistochemistry assays confirmed the expression of candidate genes. The in vivo and in vitro effects of CCAAT enhancer binding protein delta (CEBPD, C/EBP-delta) and DNA damage-inducible transcript 4 (DDIT4) on oxidative stress, cell proliferation, and angiogenesis in endometriotic cells were validated using loss- or gain-of-function approaches. Results: CEBPD was highly expressed in ectopic and eutopic endometrial tissue from patients with endometriosis. Loss- or gain-of-function experiments showed that CEBPD promoted oxidative stress, cell proliferation, and angiogenesis in vitro and in vivo. Integration of RNA-seq and online data revealed that CEBPD regulates DDIT4 expression, subsequently increasing oxidative stress, cell proliferation, and angiogenesis in endometriotic cells. Finally, CEBPD and DDIT4 were found to regulate the expression of extracellular signal-regulated kinase 1/2 (ERK1/2) proteins associated with the mitogen-activated protein kinase (MAPK) signaling pathway. Conclusions: These results suggest that CEBPD may promote oxidative stress, cell proliferation, and angiogenesis in EM by activating MAPK via DDIT4. Hence, CEBPD may be a potential target for diagnosing and treating EM.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (34)
- Comprehensive Analysis of RNA-Seq in Endometriosis Reveals Competing Endogenous RNA Network Composed of circRNA, lncRNA and mRNA via openalex
- Curcumin and Endometriosis via openalex
- Curcumin modulates oxidative stress to inhibit pyroptosis and improve the inflammatory microenvironment to treat endometriosis via openalex
- History of Endometriosis Is Independently Associated with an Increased Risk of Ovarian Cancer via openalex
- Pathogenesis of Endometriosis: New Insights into Prospective Therapies via openalex
- ‘Physio-EndEA’ Study: A Randomized, Parallel-Group Controlled Trial to Evaluate the Effect of a Supervised and Adapted Therapeutic Exercise Program to Improve Quality of Life in Symptomatic Women Diagnosed with Endometriosis via openalex
- RNA sequencing‐based long non‐coding RNA analysis and immunoassay in ovarian endometriosis via openalex
- The heterogeneity of fibrosis and angiogenesis in endometriosis revealed by single-cell RNA-sequencing via openalex
- The role of inflammation, oxidative stress, angiogenesis, and apoptosis in the pathophysiology of endometriosis: Basic science and new insights based on gene expression via openalex
- W2944735768 via openalex
- W2955485789 via openalex
- W3015534438 via openalex
- W3083187254 via openalex
- W3085013316 via openalex
- W3176222537 via openalex
- W3197723758 via openalex
- W4228997944 via openalex
- W4318240412 via openalex
- W4365515919 via openalex
- W4379524360 via openalex
- W4382894979 via openalex
- W4387077704 via openalex
- W4392856968 via openalex
- W4398176465 via openalex
- W2107277218 via openalex
- W4406980695 via openalex
- W2144397374 via openalex
- W2580806228 via openalex
- W2802314963 via openalex
- W2803375800 via openalex
- W2913526841 via openalex
- W2914562289 via openalex
- W2919754651 via openalex
- W2938892895 via openalex
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-16T00:31:22.445884+00:00
License: CC0
· commercial use OK